The well-studied B-domain from Staphylococcal protein A is a 59 amino acid three-helix bundle that binds the Fc portion of IgG with a dissociation constant of~35 nM. The B-domain variant bearing a Gly to Ala mutation (=Z-domain) has been the subject of efforts to minimize a domain's size while retaining its function. We report X-ray crystallographic characterization of three steps in such a process using complexes with Fc: the full three-helix Z-domain, a 34 amino acid two-helix version called Z34C and a 13 amino acid single helix stabilized with an exo-helix tether, called LH1.
Introduction
The design or discovery of small molecule ligands that bind at proteinprotein interfaces (PPIs) has proven to be a challenge (Bakail and Ochsenbein, 2016) . Enzyme active sites offer pockets which can shield a small molecule from solvent and provide specificity related directly to the shape of the pocket. Protein-protein-binding sites tend to be larger and flatter. In the absence of a discrete binding pocket, the competition with solvent is high and the specific charge-charge and polar interactions will be relatively weak. The relatively large surface areas of PPIs provide beneficial entropy increases by displacing solvent molecules as they maximize intermolecular contacts. Interest in dissecting and interfering with PPIs has evolved to a wide range of protein/peptide molecular mimics (Flygare et al., 2012; Pelay-Gimeno et al., 2015) including successful mimicry of α-helices by non-peptidic small molecules (Azzarito et al., 2013; Lao et al., 2014; Wilson, 2015) .
As a useful precursor to peptide mimicry, we sought general approaches for identifying PPIs where spacially well-concentrated binding energy offered some optimism that mimicry of a 'small' interface would be possible with a 'small' non-peptide molecule. Functionally important residues can be rapidly identified through alanine scanning of an interface. While PPIs typically involve large contact areas, alanine scanning has revealed that the bulk of the binding energy can often be attributed to a small subset of key residues within the larger group of 'contact' residues (Clackson and Wells, 1995) . These results suggest that it may be possible to design smaller frameworks that display the same critical components in the correct functional orientation. If the size and structural flexibility of the molecule can be reduced and the binding site can be focused onto a smaller region, the design and synthesis of small molecule PPI inhibitors could be greatly facilitated. This approach would provide a link between the structural and functional analysis of protein-protein interactions and the design of small molecule ligands.
The interaction between the B-domain of Staphylococcus aureus Protein A and the Fc of human IgG provides an ideal system for this study. The B-domain from Protein A is a three-helix bundle of 59 amino acid residues. Helices 1 and 2 form contacts with Fc and Helix 3 does not (Deisenhofer, 1981) . As an independent folding unit for which there was both biochemical and structural data, a commonly studied variant of the B-domain known as Z-domain has an Ala/Val substitution at its N-terminus and a Gly/Ala substitution in the middle of Helix 2, which removes a hydroxylamine sensitive site Asn-Gly (Nilsson et al., 1987) . This Z-domain was used as a scaffold for protein minimization experiments, in which the three-helix bundle was first truncated by deletion of Helix 3, thereby reducing the affinity by >10 5 -fold (K D > 1mM) (Braisted and Wells, 1996) . Affinity was recaptured (K D of 43nM) by use of structure-based design and phage display techniques to identify a new 33 residue protein with 12 amino acid replacements. In a subsequent step, stability of this protein was increased by adding a disulfide link near the Nand C-termini to produce the protein called Z34C (Starovasnik et al., 1997) (Table I ). The Z34C retains high affinity to the Fc yet is about one half the original size of the B-domain. A final minimization step simply dispensed with the second helix of Z34C to produce a 14 amino acid peptide. This peptide was reported to have unmeasurably low affinity for Fc (Braisted et al., 2001) . Therefore, a special covalent link was engineered between side chains of residues i and i+7 (glutamine and glutamic acid), and resulting peptide 'LH1' showed approximately millimolar affinity for Fc (Braisted et al., 2001) .
In order to track the fidelity with which key interactions are retained in this minimization process, we present here crystal structures of human IgG1 Fc complexed to the Z-domain variant of protein A at 2.5 Å, Z34C at 1.95 Å and a single (tethered) helix termed LH1 at 1.70 Å resolution. To aid in discussing the structure comparisons, we update dissociation contants for all three peptides using contemporaneous measurements and modern best practice.
Materials and methods
Peptide and protein production and purification Z-domain (Nilsson et al., 1987) and Z34C peptide (Starovasnik et al., 1997) for crystallography were produced according to the literature. The Z-domain protein used in Octet measurements was produced in Escherichia coli as a C-terminal flag-tag protein and purified using anti-flag affinity chromatography. The tethered helix LH1 peptide FNM(X)QQRRFY(Z)ALH (Braisted et al., 2001) (example #2 in US patent 6271198 B1) was synthesized using Fmoc chemistry with standard solid phase protocols in which Fmoc-glutamic acid, O-(5-allyloxycarbonyl-1,5-diaminopentane) (X) and Fmoc-glutamic acid o-allyl ester (Z) (Millipore) were incorporated as standard amino acids in peptide synthesis. Cyclization to form the LH1 'lock' using (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) (HBTU) in methylene chloride/ N,N-Diisopropylethylamine (DIPEA), was performed as follows.
The N-terminus of the solid phase FNM(X)QQRRFY(Z)ALH peptide was coupled to mono tert-butyl-succinic acid and the allyl and allyloxycarbonyl protecting groups were removed using 500 mg Pd (PPh 3 ) 2 Cl 2 in 20 ml of 20% piperidine in dimethyl acetamide for 1.5 h at room temperature. The resin was then washed with 20% piperidine in dimethyl acetamide, pure dimethyl acetamide, pure dichloromethane and finally with 0.5% trifluoroacetic acid in dichloromethane. The resin was suspended in dichloromethane and 1.5 equivalents of [dimethylamino(triazolo[4,5-b] pyridin-3-yloxy)methylidene]-dimethylazanium hexafluorophosphate (HATU) with 3 eq. DIPEA in 5 ml of dimethyl acetamide was added. After 2 h the resin was checked for free amines by ninhydrin test and found to be negative. The peptide was cleaved from the resin with 95% trifluoroacetic acid 5% triethylsilane and purified using reverse phase HPLC.
Fc was prepared from a papain cleavage of CD4-IgG1-Fc fusion protein (Capon et al., 1989) which was devoid of any poly-Histidine affinity tag. A lyophilized stock of CD4-IgG fusion protein (75 mg) was diluted to 1 mg/ml in a cleavage buffer containing 20 mM MES, 230 mM mannitol, 23 mM glycine and 1.5 mg of activated papain (Worthington). The reaction mixture was placed at 37°C for 1.5 h and then stopped by addition of leupeptin. The IgG cleavage products were then loaded on to a metal chelating column (PerSeptive BioSystems) charged with CuCl 2 and Fc was eluted using an imidazole gradient at pH 7.0. The resulting fractions were assayed by SDS-PAGE. The fractions containing Fc were pooled and loaded onto a S100 sephacryl size exclusion column (Pharmacia) equilibrated in 0.15 M NaCl, 20 mM tris pH 7.5. Fractions containing Fc were then concentrated to 10 mg/ml and added in a stoichiometric amount to either Z-domain, Z34C or in the case of LH1, milligram to milligram amount (>10× LH1 molar excess).
Crystallography
Diffraction data were integrated and reduced (Otwinowski and Minor, 1997, Winn et al., 2011) and structures solved by molecular replacement (Navaza, 1994 ) using standard methods. Map inspection and model building and manipulation employed QUANTA96 (Molecular Simulations Inc.) and Coot (Emsley et al., 2010) . Refinement was performed in XPLOR (Brünger, 1992) , Phenix.refine (Adams et al., 2010) and REFMAC5 (Murshudov et al., 2011) .
Fc/Z-domain
Initial crystals appeared in Crystal Screen I (Hampton). The optimized reservoir contained 45% PEG 4K (Aldrich), 0.1M Mg acetate, 0.1M HEPES pH 7.0 mixed 50:50 with protein stock solution at 5 mg/ml. Rod-shaped crystals grew to a size of 0.25 × 0.25 × 0.50 mm after 1 week at 292K. Crystals were preserved for data collection by sudden immersion in liquid nitrogen after passing through reservoir plus 5% ethylene glycol and diffraction data collected at SSRL beamline 7-1. The structure was solved by molecular replacement through use of the Fc from previously solved 1.95 Å Fc/Z34C and the E-domain from NMR (Starovasnik et al., 1996) as search probes. Non-crystallographic symmetry (NCS) restraints were applied in refinement.
Fc/Z34C
Initial crystals appeared in Crystal Screen II (Hampton) and were optimized. The final conditions contained 20% PEG monomethyl ether 550 (FLUKA), 0.1 M bis-tris propane pH 6.5, 0.1 M NaCl and Starovasnik et al. (1997) This work B-domain 36 ± 9 nM 23.5 ± 5 nM Z-domain 31 ± 4 nM 14.9 ± 0.1 nM 25 ± 2 nM Z34C 20.0 ± 0.8 nM 27 ± 1.4 nM LH1~1 ± 0.5 mM 5mg/ml complex concentration. The crystals appear as thin parallelepipeds. Crystals were preserved for data collection by sudden immersion in liquid nitrogen using the reservoir plus an additional 5% of PEG MME 550 as a cryoprotectant. High resolution data for the Fc/ Z34C complex were collected at CHESS beamline A-1. The structure solved by molecular replacement using PDB entry 1FC1 (Deisenhofer, 1981) as search probe. During refinement of the initial solution, residues 286-296 were rebuilt and some amino acid sequence changed to reflect modern sequence information. The Z34C NMR-determined structure (PDB 1ZDD) was manually placed into Fo−Fc density which clearly showed the two helices. NCS restraints were applied in early stages of refinement and then abandoned.
Fc/LH1
Initial crystals were seen growing in Crystal Screen I (Hampton). Optimized crystals were grown by vapor diffusion in sitting drops against 20% PEG 4000 (FLUKA) and 0.1 M HEPES pH 7.2. The sitting drops contained 40 μl of complex (5 mg/ml) plus 20 μl of reservoir. Crystals appeared overnight reaching a size of 0.5 × 0.5 × 0.5 mm. Crystals were preserved for data collection by sudden immersion in liquid nitrogen using 2-methyl-2,4-pentanediol and the reservoir as a cryoprotectant and diffraction data collected at SSRL beamline 7-1. The structure was solved by molecular replacement using chain A from the Fc/Z34C complex as a molecular replacment probe. After some refinement, Helix 1 from the Fc/Z34C structure was docked and the lock residues built and refined to convergence.
Affinity determinations
Binding affinities were measured by biolayer interferometry (BLI) on an OctetRED384 instrument (ForteBio, Menlo Park, CA, USA) and surface plasmon resonance (SPR) on a Biacore S200 machine. Fcfragment was biotinylated using EZ-Link™ NHS-PEG4-Biotin from Thermo Fisher according to the manufacturer's protocol to obtain a ratio of 1-2 biotin conjugations per Fc molecule. Biotin-labeled Fcfragment was dialyzed against PBS over night afterward to remove excess biotin reagent. BLI measurements: all washes, dilutions and measurements were performed in kinetics buffer (Fortebio, USA) with the plate shaking at 1000 r.p.m. High precision streptavidin (SAX) biosensors were equilibrated in Octet buffer for 10 min and then loaded with biotinylated human Fc-fragment to a density of 2 nm and subsequently washed for 3 min. For the association phase, the ligand coated SAX tips were immersed in solutions containing Bdomain, Z-domain, Z34C peptide or LH1 peptide for 5 min (eight serial 2-fold dilutions, starting at 600 nM for Z-domain, Z34C and 600 μM for and LH1, respectively). Dissociation of the Fc-fragmentpeptide complex was measured in wells containing kinetics buffer alone for 10 min. The binding curves were fitted with Octet evaluation software v6.3 using a 1:1 binding model with local partial fit. Dissociation constants (K D ) were calculated based on the steadystate-binding analysis. All measurements were done in duplicate and background subtracted by doing parallel measurements with blank SAX biosensors. SPR measurement: Fc-fragment was directly aminecoupled to a CM5 chip at densities of 250, 450 and 700 RU to flow cell 2, 3 and 4, respectively. Association of peptide LH1 was measured at eight serial two-fold dilutions for 3 min. The starting concentration for LH1 was 600 μM. Peptide dissociation from Fc-fragment was measured for 5 min. All measurements were performed in 0.01 M HEPES pH 7.4, 0.15 M NaCl, 0.005% v/v Surfactant P20, (HBS-P buffer, GE Healthcare Life Sciences).
Results
The structure of Fc/Z-domain = '3'
The structure of the Fc from human IgG1 bound to the Z-domain was determined at 2.50 Å resolution using a single crystal and data collected at SSRL beamline 7-1 (Table II) . The space group P2 1 2 1 2 asymmetric unit contains a full Fc (two chains) and two copies of the Z-domain. The Z-domains are each well-formed three-helix bundles, interacting with Fc using Helices 1 and 2. The finding of three helices is different than for the Fc/B-domain complex (Deisenhofer, 1981) , wherein polypeptide for the Helix 3 segment was built in an extended conformation. Subsequent related results using the C-domain from protein A have included a third α-helix (Deis et al., 2015) , in agreement with our findings. Z-domain Helix 3 supports Helices 1 and 2 but does not contact Fc. The two independent copies of the Fc polypeptide superpose with an RMSD of 0.89 Å for 212 atom pairs. Superposition of CH2 and CH3 domains separately yields RMSD values of 0.73 and 0.21Å, revealing a non-zero difference in the relationship between CH2 and CH3 domains, and also a greater variability between CH2 domains. The two independent copies of the Z-domain are closely similar, Cα atoms superposing with an RMSD of 0.18 Å. The close similarity between Z-domains extends to their interface on Fc, as inclusion of Cα atoms from residues on Fc within 6 Å also yields an RMSD of 0.18 Å. Comparison of the Z-domains to the lowest energy solution structure from NMR (PDB accession 1Q2N (Zheng et al., 2004) ) yields an RMS deviation 0.94 Å for 53 Cα pairs and of 0.66 Å if two outlying pairs are ignored. The solvent accessible surface (SAS) area buried in the Fc/Z-domain interfaces is~790 Å 2 on each side (Fig. 1a) .
The structure of Fc/Z34C = '2'
The structure of the Fc from human IgG1 bound to the Z34C protein was determined before that of Fc/Z (above) at 1.95 Å resolution using diffraction data from CHESS beamline A-1 from a single crystal, and was solved using the X-ray-derived Fc (Deisenhofer, 1981) as a molecular replacement search probe (Table II) . There is one complete Fc (two chains) and two copies of Z34C in the space group P2 1 asymmetric unit. In early stages of model building, difference electron density (Fo−Fc) suggested mis-registry by two amino acid residues within the segment 285-296 of Fc. The final refined structure reflects changes in this region which have already appeared in the literature without elaboration (PDB 1DN2 (DeLano et al., 2000) ), but which also have been described in detail by Matsumiya et al., (2007) . Following some refinement, Z34C was manually placed into strong Fo−Fc electron density. The two independent Fc polypeptides show a small difference in the relationship between their CH2 and CH3 domains (as for Fc/Z above), with an RMSD for Cα atoms of 0.60 Å for entire chains and 0.28 and 0.25 Å for isolated CH2 and CH3 domains, respectively. The Cα atoms of the two copies of Z34C superpose with RMSD of 0.45 Å. The two Z34C molecules are each closely similar to the minimized mean solution structure from NMR (PDB 1ZDD (Starovasnik et al., 1997) ), with RMSD values of 0.90 Å, and of 0.39 Å if the six most poorly superposable pairs are excluded. The excluded residues are at the termini and in the loop joining the two helical segments. The two independent interfaces between Z34C and Fc are also closely similar, as the RMSD values for superposition of Cα atoms of Z34C plus Fc residues within 6 Å of Z34C is 0.42 Å. Pairwise superpositions of the two Z34C copies with the two Z-domain copies from the Fc/Z-domain complex yields an average RMSD value of 0.71 ± 0.01Å for all corresponding Cα pairs, and of 0.48 ± 0.02 Å excluding three outlying pairs. The Fc/Z34C interface obscures 735 Å 2 of surface of each protein from solvent (Fig. 1b) .
The Z34C peptide comprises two antiparallel α-helices constrained by a disulfide between the terminal segments, consistent with the originating three-helix Z-domain and as already confirmed by NMR (Starovasnik et al., 1997) . The original X-ray structure of the Bdomain bound to Fc (Deisenhofer, 1981) showed that residues 1-5 were disordered and are completely absent in Z34C by design. Thus, the Z34C peptide starts at Phe6. The helices of Z34C are virtually identical to Helices 1 and 2 of the Z-domain in the Fc/Z complex described above. The Z34C is well defined having an average temperature factor of 26 Å 2 . Almost all of the side chains are within the Z34C 2Fo−Fc electron density contoured at one time RMSD. No waters are found in the interface between the Fc and the Z34C and only a few are found on the periphery of the interface. The disulfide is formed between residues Cys10 and Cys39 having a Cα-Cα distance of 6.2 Å.
Five amino acids which each lose 60-100 Å 2 of SAS to their Fc contacts are conserved between Z-domain and Z34C: Phe6, Gln11, Fig. 1 The surfaces of Fc colored cyan for residues within 4 Å of (a) Z-domain (b) Z34C and (c) LH1. Sidechain atoms from five residues conserved in all versions of Helix 1 are in black. In black outline are cylinders representing α-helices, for (a) Z-domain the outline for Helix 3 is omitted for clarity, Helix 3 having no resides contributing to the cyan coloring.
Phe14, Tyr15 and Leu18 (Fig. 2 ). Of these, Phe6, Phe14 and Leu18 side chains are in hydrophobic contact with Fc: Met252, Ile253 and (Gln311/Leu314), respectively. The Gln11 side chain forms three Hbonds with Fc, from the amide NH of Ile253 and to the amide carbonyl oxygen atoms of Leu251 and Asn434. The Tyr15 side chain aromatic ring is perpendicular to and accepts an H-atom from the main chain N-H bond of Fc Asn434. There are several amino acid substitutions between Z-domain and Z34C that arose during the affinity maturation of the initial two-helix truncated form (Braisted and Wells, 1996) . Some of these are of a relatively conservative nature, for instance Glu/Gln at residue nine and Gln/Lys at residue 33, that are solvent exposed in both three and two helices proteins, with zero or very little contact with Fc. Other changes reflect greater solvent exposure from the absence of Helix 3, for instance Ala/Arg at residue 13, Ile/Ala at residue 17, Leu/Asp at residue 20 and Phe/Lys at residue 31. The substitution Lys/Met at residue eight is less stark than at first consideration, as moderately sized contacts of either residue are hydrophobic in their nature. A remaining substitution is less straightforward to rationalize, the Asn/Arg change at residue 12, the effect of which is loss of an H-bond with Fc Asn434. The Fc from the Fc/Z34C complex was used to solve the two other complexes.
The structure of Fc/LH1 = '1'
The structure of the Fc from IgG1 bound to the single tethered helix LH1 was determined at 1.70 Å resolution using data from two crystals, collected using X-rays from a rotating anode and from SSRL beamline 7-1 (Table II) . The space group C222 1 asymmetric unit contains onehalf an Fc and one copy of LH1, the intact Fc complex generated by a crystallographic 2-fold axis. The LH1 helix binds Fc in the same fashion as in both the three-helix Z-domain and two-helix Z34C versions. Lost SAS is~630 Å 2 on each side (Fig. 1c) . The single helix also has well ordered density for the locking residues (Fig. 3) . The Fc Cα atoms of Fc/LH1 superpose with Fc from Fc/Z34C with RMSD values of 1.2 Å for the entire chain and of 0.79 Å for individual CH2 and CH3 domains. Similarly, superposition with Fc from Fc/Z-domain yields RMSD values of 1.12 Å for the entire chain and of 1.05 Å for CH2 domains and of 0.81 Å for CH3 domains. The analogous LH1 Cα atoms superpose with those of Z34C with RMSD values of~0.35 Å while ignoring the significant divergence (4.0 Å) in the positions of His19 Cα atoms. The divergence of His19 in LH1 creates a relatively small contact with Fc residue Asn315 that is not present for Fc/Z-domain or Fc/Z34C. This contact is of a geometry which is not consistent with an H-bond.
Affinity determination for Z-domain, Z34C and LH1 binding to Fc
The affinities of all three peptides were measured by BLI and SPR at different peptide concentrations while the Fc-domain was immobilized on the sensor surface of both technologies ( Fig. 5 and see Supplementary data). Z-domain and Z34C had K D values of 25 and 27 nM by BLI, which is in very good agreement with previous measurements (Starovasnik et al., 1997) . LH1 showed significant background binding to SAX biosensors for BLI, which was difficult to reduce to determine the affinity accurately. Attempts to determine the affinity of LH1 by SPR were almost equally challenging. Due to the weak affinity of LH1, high enough concentrations could not be achieved to obtain the equilibrium binding level maximum (R eq ) in the measurements to accurately determine the affinity. Thus, only an approximate K D of 1 ± 0.5 mM Fig. 4 Stereo image of contacts region for Z-domain, Z34C and LH1 complexes with Fc. The structures were superposed using the Fc protein chains (green, using simplified main chain representations). The Z-domain (light gray), Z34C (medium gray) and LH1 (dark gray) are shown as stylized main chains, with side chains added for residues within 4 Å of Fc. was determined straightforward on the fitted data without reaching R eq at the highest concentration.
Discussion
The process of design and discovery of shrunken versions of the Zdomain revealed amino acid residue-specific contributions to protein/ peptide stability and Fc-binding energy (Braisted and Wells, 1996; Starovasnik et al., 1997; Braisted et al., 2001) . However, inherent in this work were assumptions about the constancy of key features of interactions with Fc. For instance, if a residue (e.g. Phe6 or Gln11 or other) provides key interactions with Fc when it appears in Z-domain, does it also provide closely similar interactions in the context of Z34C or LH1? Are the Fc residues involved in key interactions the same for all three peptides, or has the Fc 'epitope' shifted?
The NMR study of Z34C confirmed the intended two-helix structure, but side chain contacts with Fc were beyond the scope of that study. Therefore, we undertook the present detailed structural assessment to learn if there were important caveats attached to the discovery program leading to LH1. The crystal structures presented here reveal that both Z34C and LH1 provide key interactions with Fc that very faithfully recapitulate a large subset of those present in the Fc/Z-domain interface (Fig. 4) . By providing this confirmation, we bolster confidence in key early steps in a path to discovery of small molecules as surrogates for stable protein domains. If one focuses on direct interactions with Fc provided by Zdomain, the last helix of Z-domain, Helix 3, is understood to stabilize Helices 1 and 2, but not to interact with Fc. Thus, deletion of Helix 3 is tolerated if a different stabilizing influence is substituted, such as the disulfide link in Z34C connecting Helices 1 and 2. And, while direct interactions with Fc are provided by Helix 2, even it can be deleted if the loss of its interactions with Fc can be tolerated and a different means to stabilize Helix 1 is found, like the covalent connection between side chains in the single helix of LH1. However, the direct interactions provided by Helix 2 are simply absent, and not replaced in any way, when Z-domain is shrunken to a single helix with a reduction in buried surface area of~14%. The relatively low affinity of LH1 binding to Fc is, therefore, to be expected (Fig. 5) . Nonetheless, the smallest of the Fc-binding partners is a worthy starting point for considering non-peptidic helix-mimic small molecules.
Deposition
Atomic coordinates and structure factors for X-ray structures reported here are deposited in the Protein Data Bank under accession codes 5U4Y, 5U52 and 5U66 for Fc/Z-domain, Fc/Z34C and Fc/LH1, respectively.
